Replacement of Adenovirus Type 5 Fiber Shaft Heparan Sulfate Proteoglycan-Binding Domain with RGD for Improved Tumor Infectivity and Targeting-Reference-Cited by-同舟云学术

Replacement of Adenovirus Type 5 Fiber Shaft Heparan Sulfate Proteoglycan-Binding Domain with RGD for Improved Tumor Infectivity and Targeting

Published:2009-10 Issue:10 Volume:20 Page:1214-1221
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Bayo-Puxan Neus¹,Gimenez-Alejandre Marta¹,Lavilla-Alonso Sergio²,Gros Alena¹,Cascallo Manel¹,Hemminki Akseli²,Alemany Ramon¹

Affiliation:

1. Translational Research Laboratory, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL)-Institut Català d'Oncologia, L'Hospitalet de Llobregat, 08907 Barcelona, Spain.

2. University of Helsinki, Cancer Gene Therapy Group, Molecular Cancer Biology Program, and Haartman Institute and Finnish Institute for Molecular Medicine, 00290 Helsinki, Finland.

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/hum.2009.038

Reference30 articles.

1. CAR-binding ablation does not change biodistribution and toxicity of adenoviral vectors

2. Cancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse Model

3. The Influence of Blood on In Vivo Adenovirus Bio-distribution and Transduction

4. Role of the putative heparan sulfate glycosaminoglycan-binding site of the adenovirus type 5 fiber shaft on liver detargeting and knob-mediated retargeting

5. Isolation of a Common Receptor for Coxsackie B Viruses and Adenoviruses 2 and 5

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A PD-L1 tropism-expanded oncolytic adenovirus enhanced gene delivery efficiency and anti-tumor effects;International Immunopharmacology;2024-08

2. Harnessing adenovirus in cancer immunotherapy: evoking cellular immunity and targeting delivery in cell-specific manner;Biomarker Research;2024-03-25

3. Oncolytic adenovirus coding for shedding-resistant MICA enhances immune responses against tumors;Cancer Immunology, Immunotherapy;2024-01

4. Oncolytic viruses in immunotherapy;Cancer Immunology and Immunotherapy;2022

5. Vascular Endothelial Cells: Heterogeneity and Targeting Approaches;Cells;2021-10-10